KANEKO YASUNORI

CIK 000127750313 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001277503

Recent Transactions

50 trades

Award
Arcus Biosciences, Inc.$RCUS
Stock Option (Right to Buy)
2025-06-10+38,300→ 38,300 total
Award
Arcus Biosciences, Inc.$RCUS
Common Stock
2025-06-10+13,300→ 33,300 total
Purchase
Arcus Biosciences, Inc.$RCUS
Common Stock
2025-02-27$10.06/sh+20,000→ 28,400 total
Award
Arcus Biosciences, Inc.$RCUS
Common Stock
2024-06-06+8,400→ 15,200 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (Right to Buy)
2024-06-06+24,000→ 24,000 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (Right to Buy)
2023-06-15+19,500→ 19,500 total
Award
Arcus Biosciences, Inc.$RCUS
Common Stock
2023-06-15+6,800→ 6,800 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (Right to Buy)
2022-06-14+16,800→ 16,800 total
Award
Arcus Biosciences, Inc.$RCUS
Common Stock
2022-06-14+4,100→ 4,100 total
Award
Arcus Biosciences, Inc.$RCUS
Common Stock
2021-06-03+3,000→ 6,000 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (Right to Buy)
2021-06-03+14,100→ 14,100 total
Purchase
Arcus Biosciences, Inc.$RCUS
Common Stock
2021-04-23$31.37/sh+4,133→ 7,133 total
Exercise/Conversion
Arcus Biosciences, Inc.$RCUS
Common Stock
2020-06-05$7.99/sh+35,000→ 38,000 total
Exercise/Conversion
Arcus Biosciences, Inc.$RCUS
Stock Option (Rights to Buy)
2020-06-05−35,000→ 0 total
Award
Arcus Biosciences, Inc.$RCUS
Common Stock
2020-06-04+3,000→ 3,000 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (Right to Buy)
2020-06-04+14,000→ 14,000 total
Award
Arcus Biosciences, Inc.$RCUS
Stock Option (Right to buy)
2019-06-06+35,000→ 35,000 total
Conversion
SI-BONE, Inc.$SIBN
Common Stock
2018-10-19+398,676→ 4,094,985 total
Purchase
SI-BONE, Inc.$SIBN
Common Stock
2018-10-19$15.00/sh+325,000→ 4,419,985 total
Conversion
SI-BONE, Inc.$SIBN
Series 7 Preferred Stock
2018-10-19−398,676→ 0 total
Sale
SI-BONE, Inc.$SIBN
Series 5 Preferred Stock
2018-10-19$14.00/sh−23,904→ 792,195 total
Conversion
SI-BONE, Inc.$SIBN
Series 4 Preferred Stock
2018-10-19−2,213,425→ 0 total
Conversion
SI-BONE, Inc.$SIBN
Series 5 Preferred Stock
2018-10-19−792,195→ 0 total
Conversion
SI-BONE, Inc.$SIBN
Series 6 Preferred Stock
2018-10-19−652,347→ 0 total
Conversion
SI-BONE, Inc.$SIBN
Common Stock
2018-10-19+690,689→ 3,696,309 total
Exercise of In-Money
SI-BONE, Inc.$SIBN
Warrant (right to buy)
2018-10-19−39,421→ 0 total
Exercise of In-Money
SI-BONE, Inc.$SIBN
Series 5 Preferred Stock
2018-10-19+39,421→ 816,099 total
Conversion
SI-BONE, Inc.$SIBN
Common Stock
2018-10-19+2,213,425→ 2,213,425 total
Conversion
SI-BONE, Inc.$SIBN
Common Stock
2018-10-19+792,195→ 3,005,620 total
Conversion
SUTRO BIOPHARMA, INC.$STRO
Series C Preferred Stock
2018-10-01−25,015,635→ 0 total
Conversion
SUTRO BIOPHARMA, INC.$STRO
Series E Preferred Stock
2018-10-01−18,698,578→ 0 total
Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2018-10-01+520,264→ 1,445,842 total
Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2018-10-01+925,578→ 925,578 total
Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2018-10-01+514,211→ 1,960,053 total
Conversion
SUTRO BIOPHARMA, INC.$STRO
Series D Preferred Stock
2018-10-01−12,846,023→ 0 total
Conversion
Arcus Biosciences, Inc.$RCUS
Series B Convertible Preferred Stock
2018-03-19−252,524→ 0 total
Conversion
Arcus Biosciences, Inc.$RCUS
Common Stock
2018-03-19+252,524→ 252,524 total
Conversion
Arcus Biosciences, Inc.$RCUS
Series C Convertible Preferred Stock
2018-03-19−2,565→ 0 total
Conversion
Arcus Biosciences, Inc.$RCUS
Common Stock
2018-03-19+505,050→ 505,050 total
Conversion
Arcus Biosciences, Inc.$RCUS
Common Stock
2018-03-19+33,818→ 96,948 total
Conversion
Arcus Biosciences, Inc.$RCUS
Series A Convertible Preferred Stock
2018-03-19−505,050→ 0 total
Conversion
Arcus Biosciences, Inc.$RCUS
Series B Convertible Preferred Stock
2018-03-19−31,253→ 0 total
Other
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2017-12-05+270→ 270 total
Other
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2017-12-05−800,000→ 2,149,916 total
Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2015-05-12+1,552,795→ 1,552,795 total
Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Series B Convertible Preferred Stock
2015-05-12−10,714,286→ 0 total
Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2015-05-12+382,323→ 1,935,118 total
Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Series D Convertible Preferred Stock
2015-05-12−5,881,724→ 0 total
Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2015-05-12+864,798→ 2,799,916 total
Purchase
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2015-05-12$12.00/sh+150,000→ 2,949,916 total

KANEKO YASUNORI

Recent Transactions

Companies

Recent Filings

Address